Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-41360

medium

OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows.

Vendor / product: Openclaw — openclaw

OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.

CVSS
6.7
6.7 (CVSS v3.1)
CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
Severity source: NVD CVSS v3.1 (disclosure@vulncheck.com)
Timeline (UTC)
Published: 2026-04-23 22:16
Modified: 2026-11-11 23:10
NVD status: Analyzed
Last synced 3 hours ago
Verified against the source API 2026-11-11 23:12 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

openclaw / openclaw <2026.4.2

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

Vendor advisory: https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcj
Patch / mitigation: https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859eeff

References

Data sources

NVD CVE API 2.0 — fetched 2026-11-11 23:12 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores

Related CVEs